Verve Therapeutics, Inc. short interest in 2021
In 2021, Verve Therapeutics, Inc.'s disclosed short interest ran from 3.31% of shares outstanding on 13 Aug 2021 to 12.74% on 31 Dec 2021, a change of +9.43 percentage points. The year's high was 12.74% on 31 Dec 2021 and its low 3.31% on 13 Aug 2021, averaging 7.10% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.60 days on 29 Oct 2021. Full history: Verve Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2021 in figures
- Start of year
- 3.31% (13 Aug 2021)
- End of year
- 12.74% (31 Dec 2021)
- Change
- +9.43 pp
- High
- 12.74% (31 Dec 2021)
- Low
- 3.31% (13 Aug 2021)
- Average
- 7.10%
- Highest days to cover
- 16.60 (29 Oct 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Aug 2021 | 3.31% | 5.24 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 3.88% | 7.19 | |
| 15 Sep 2021 | 3.93% | 5.12 | |
| 30 Sep 2021 | 4.63% | 3.02 | |
| 15 Oct 2021 | 6.21% | 10.33 | |
| 29 Oct 2021 | 6.92% | 16.60 | |
| 15 Nov 2021 | 7.98% | 16.03 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 9.66% | 11.11 | |
| 15 Dec 2021 | 11.75% | 12.09 | |
| 31 Dec 2021 | 12.74% | 7.00 |
See also: Verve Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.